105. MDMA medicalisation in the US with Dr Julie Holland

In this episode we meet with Dr Julie Holland. 

She discussed how MDMA influenced her career and inspired her to investigate its therapeutic potential. Controversially, she has investigated the effect of MDMA in schizophrenia and its potential in preventing paranoia and inhibiting auditory hallucinations during its effects. 

Dr Holland touches upon debate subjects such as the likelihood of addiction following consumption of MDMA as well as classifications of various substances under regulatory bodies. 

Finally, Dr Holland highlights the ‘alpha bias’ in current clinical research as expressed through her book ‘moody bitches’ and indicates the implications this could have.

Moody Bitches Book

Good Chemistry book

Maps 

Mdma

Mescaline

PCP

LSD

Cannabis

Fentanyl

Benzodiazapines

Ketamine

Psilocybin

Psilocybin psychotherapy

Schizophrenia

Anxiety

PTSD

Eating Disorders

Rosalind Watts

Norman Ohler

Telehealth Ketamine Study

Become a Drug Science Community Member

★ Support this podcast ★

What is The Drug Science Podcast?

Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.